The relative contributions of HIV drug resistance, nonadherence and low-level viremia to viremic episodes on antiretroviral therapy in sub-Saharan Africa
<p><strong>Introduction: </strong> To achieve viral suppression among more than 90% of people on antiretroviral therapy (ART), improved understanding is warranted of the modifiable causes of HIV viremic episodes. We assessed the relative contributions of drug-resistance, nonadheren...
Main Authors: | Inzaule, SC, Bertagnolio, S, Kityo, CM, Siwale, M, Akanmu, S, Wellington, M, de Jager, M, Ive, P, Mandaliya, K, Stevens, W, Boender, TS, Ondoa, P, Sigaloff, KCE, Rinke de Wit, TF, Hamers, RL |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Wolters Kluwer
2020
|
Similar Items
-
Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance
by: Inzaule, S, et al.
Published: (2018) -
Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance
by: Seth C. Inzaule, et al.
Published: (2018-10-01) -
Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa
by: Boender, T, et al.
Published: (2016) -
Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa
by: Boender, T, et al.
Published: (2016) -
Curbing the rise of HIV drug resistance in low-income and middle-income countries: the role of dolutegravir-containing regimens
by: Inzaule, SC, et al.
Published: (2019)